PRESIDIO PHARMACEUTICALS
Presidio Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the discovery, in-licensing, development and commercialization of novel therapeutics for viral infections, including HCV and HIV. Presidio has raised over $27 million in financing from Panorama Capital, Baker Brothers Investments, Bay City Capital, Ventures West, Nexus Medical Partners, and Sagamore Bioventures LLC.
PRESIDIO PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2006-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.presidiopharma.com
Total Employee:
11+
Status:
Active
Contact:
415-655-7560
Email Addresses:
[email protected]
Total Funding:
100.18 M USD
Technology used in webpage:
Domain Not Resolving SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Rackspace Email Hosting Yahoo Image CDN UltraDNS Neustar Yahoo Web Analytics Telepacific Communications
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Mizner Bioscience
Mizner Bioscience discovers, develops, and commercializes generic therapies drugs and medical solutions to animal health market.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Panorama Capital
Panorama Capital investment in Venture Round - Presidio Pharmaceuticals
New Leaf Venture Partners
New Leaf Venture Partners investment in Venture Round - Presidio Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Venture Round - Presidio Pharmaceuticals
New Leaf Venture Partners
New Leaf Venture Partners investment in Venture Round - Presidio Pharmaceuticals
Bay City Capital
Bay City Capital investment in Series B - Presidio Pharmaceuticals
Nexus Medical Partners
Nexus Medical Partners investment in Series B - Presidio Pharmaceuticals
Ventures West
Ventures West investment in Series B - Presidio Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series B - Presidio Pharmaceuticals
Panorama Capital
Panorama Capital investment in Series B - Presidio Pharmaceuticals
Sagamore Bioventures
Sagamore Bioventures investment in Series A - Presidio Pharmaceuticals
Official Site Inspections
http://www.presidiopharma.com
- Host name: crs.ultradns.net
- IP address: 204.74.99.100
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Presidio Pharmaceuticals"
Presidio Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Www.presidiopharma.com. Holding Company | 2006 | California, United States | 10-50 | www.presidiopharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Presidio Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Presidio Pharmaceuticals, Inc. of San Francisco, CA. Get the latest business insights from Dun & …See details»
Presidio Pharmaceuticals, Inc. Information - RocketReach
What is the annual revenue of Presidio Pharmaceuticals, Inc.? The Presidio Pharmaceuticals, Inc. annual revenue was $6.7 million in 2024.See details»
Presidio Pharmaceuticals - PitchBook
Presidio Pharmaceuticals General Information Description. Developer of small-molecule antiviral therapeutics designed to treat viral infections. The company's antiviral therapeutics offer daily oral dosing and can be combined with other …See details»
Presidio Pharmaceuticals - Products, Competitors, Financials, …
Headquarters Location. 1700 Owens Street Suite 585. San Francisco, California, 94158, United States. 415-655-7560See details»
Presidio Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
Presidio Pharmaceuticals contact info: Phone number: (415) 655-7560 Website: www.presidiopharma.com What does Presidio Pharmaceuticals do? Presidio …See details»
Presidio Pharmaceuticals, Inc - VentureRadar
Presidio Pharmaceuticals, Inc. is a San Francisco-based clinical-stage pharmaceutical company dedicated to the development and licensing of its... ... Find out more ...See details»
Presidio Pharmaceuticals - Craft
Presidio Pharmaceuticals is a clinical-stage pharmaceutical company. It is dedicated to the development and licensing of its small-molecule antiviral therapeutic, ravidasvir (PPI-668) in …See details»
Investors | Presidio Pharmaceuticals
Presidio Pharmaceuticals, Inc. 1700 Owens Street, Suite 184 San Francisco, CA 94158 USA Phone: 415-655-7560 EmailSee details»
Presidio Pharmaceuticals - Portfolio Company Profile, Executives …
See Presidio Pharmaceuticals's complete profile, including its private equity owner and the number of its executive contacts in our database. Presidio Pharmaceuticals, Inc. is building a …See details»
Presidio Pharmaceuticals, Inc. - Company Profile & Staff
Presidio Pharmaceuticals, Inc. is a San Francisco-based clinical-stage pharmaceutical company dedicated to the discovery and development of small-molecule antiviral therapeutics. …See details»
Presidio Pharmaceuticals - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Presidio Pharmaceuticals, Inc. Raises $27 Million in Additional ...
Jul 10, 2009 For more information, please visit our website at www.presidiopharma.com. Contact: Presidio Pharmaceuticals, Inc. Omar K. Haffar, Ph.D., 415-655-7561 President and …See details»
Presidio Pharmaceuticals Closes $26 Million Series B Financing
Aug 29, 2007 Presidio Pharmaceuticals was founded in March 2006 with an initial investment from Sagamore Bioventures, a life science venture fund headquartered in San Francisco, CA, …See details»
Emerging Drug Developer: Presidio Pharmaceuticals - Fierce Biotech
Presidio anticipates bright future for HCV cocktail therapies When Presidio Pharmaceuticals first opened its doors in 2006, the developer was concentrating on new antivirals for the HIV …See details»
Presidio Pharma Raises $27 Million - venturecapitaljournal.com
Jul 10, 2009 Presidio Pharmaceuticals Inc., a San Francisco-based drug company focused on small-molecule compounds to treat HIV-1, HCV and other chronic viral infections, has raised …See details»
Eric Ruby Joins Presidio Pharmaceuticals, Inc. as Vice President of ...
Jan 12, 2010 Eric Ruby Joins Presidio Pharmaceuticals, Inc. as Vice President of Regulatory Affairs SAN FRANCISCO - (Business Wire) Presidio Pharmaceuticals, Inc. is pleased to …See details»
Presidio Pharmaceuticals, Inc. Initiates First-in-Human ... - NATAP
Presidio Pharmaceuticals, Inc. Initiates First-in-Human Clinical Trial of PPI-461, an Investigational NS5A Inhibitor for HCV 2010-04-27 Presidio Pharmaceuticals, Inc. announced today that the …See details»
Presidio Pharmaceuticals, Inc. Announces Positive Results in a …
Mar 30, 2011 SAN FRANCISCO--(BUSINESS WIRE)-- Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel …See details»